Context Therapeutics Preferred Securities out of Shareholders Equity (Quarterly) Trends

Context Therapeutics, Inc. (CNTX)

2.43 -0.05 (-2.02%) USD | NASDAQ | Feb 25, 16:00

2.43 0.00 (0.00%) After-Hours: 16:53

View Preferred Securities out of Shareholders Equity (Quarterly) for CNTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Preferred Securities out of Shareholders Equity (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Preferred Securities out of Shareholders Equity (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Preferred Securities out of Shareholders Equity (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Imunon, Inc.	--